menu search

Surrozen's inflammatory bowel disease candidate shows encouraging preclinical action

Surrozen Inc (NASDAQ: SRZN) announced that preclinical data from its inflammatory bowel disease (IBD...

October 6, 2021, 7:17 am


Search within

Pages Search Results: